MedTrace Logo

Tolerance of an Oral Nutritional Supplement(ONS)

NCT01782456 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2013-06-03

No results posted yet for this study

Summary

The objective of this study is to capture information on gastrointestinal tolerance (GI) of an oral nutritional supplement containing a new protein blend in healthy children aged ≥ 3 to ≤ 10 years.

Conditions

  • Gastro-Intestinal Tolerance

Interventions

OTHER

Study Oral Nutritional Supplement

Supplement contains a new protein mix consisting of a blend of milk, soy, and pea protein.

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Jennifer Williams, MPH · Abbott Nutrition

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01782456 on ClinicalTrials.gov